Ranganath Gopalakrishnan
Company: AstraZeneca
Job title: Director, New Modalities Medicinal Chemistry, Early CVRM
Seminars:
Understanding the Limitations, Possibilities & Complementarity of Computational & Medicinal Chemistry Advancements to Predict Peptide Structure & Function 9:15 am
Currently, one of the biggest bottlenecks holding the peptide therapeutic space back from success is the lack of crystal structure data for peptides, making it difficult to understand the 3D nature of interactions of peptides with themselves, other proteins, and ligands. There is a need to advance computational technologies that will help with peptide structure…Read more
day: Pre-Conference Workshop Day